🇺🇸 FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12421308

Anti-G-CSF antibodies and uses thereof

ME Therapeutics Inc. · Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12246059

Stable hybrid FC fusion G-CSF formulation

ILKOGEN ILAÇ SANAYI VE TICARET A.S. · Granted Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11813310

Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia

ILKOGEN ILAÇ SANAYI VE TICARET A.S. · Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813913

Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor

United States Government as represented by the Department of Veterans Affairs · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10376495

Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor

The United States Government as Represented by the Department of Veterans · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524655

Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders

Northwestern University · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted